We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
UnitedHealth Group (UNH) Sees a More Significant Dip Than Broader Market: Some Facts to Know
Read MoreHide Full Article
UnitedHealth Group (UNH - Free Report) closed the most recent trading day at $282.65, moving -1.88% from the previous trading session. The stock's performance was behind the S&P 500's daily loss of 0.01%. Meanwhile, the Dow experienced a drop of 0.32%, and the technology-dominated Nasdaq saw an increase of 0.05%.
Shares of the largest U.S. health insurer witnessed a loss of 6.23% over the previous month, trailing the performance of the Medical sector with its loss of 1.59%, and the S&P 500's gain of 5.37%.
Market participants will be closely following the financial results of UnitedHealth Group in its upcoming release. The company plans to announce its earnings on July 29, 2025. The company is predicted to post an EPS of $4.94, indicating a 27.35% decline compared to the equivalent quarter last year. Our most recent consensus estimate is calling for quarterly revenue of $111.6 billion, up 12.89% from the year-ago period.
UNH's full-year Zacks Consensus Estimates are calling for earnings of $21.38 per share and revenue of $448.65 billion. These results would represent year-over-year changes of -22.7% and +12.08%, respectively.
Investors might also notice recent changes to analyst estimates for UnitedHealth Group. Recent revisions tend to reflect the latest near-term business trends. Hence, positive alterations in estimates signify analyst optimism regarding the business and profitability.
Our research demonstrates that these adjustments in estimates directly associate with imminent stock price performance. To exploit this, we've formed the Zacks Rank, a quantitative model that includes these estimate changes and presents a viable rating system.
The Zacks Rank system, which ranges from #1 (Strong Buy) to #5 (Strong Sell), has an impressive outside-audited track record of outperformance, with #1 stocks generating an average annual return of +25% since 1988. Over the last 30 days, the Zacks Consensus EPS estimate has witnessed a 4.02% decrease. UnitedHealth Group is currently a Zacks Rank #4 (Sell).
Digging into valuation, UnitedHealth Group currently has a Forward P/E ratio of 13.47. This valuation marks a premium compared to its industry average Forward P/E of 12.97.
We can also see that UNH currently has a PEG ratio of 1.41. This metric is used similarly to the famous P/E ratio, but the PEG ratio also takes into account the stock's expected earnings growth rate. The Medical - HMOs industry had an average PEG ratio of 0.9 as trading concluded yesterday.
The Medical - HMOs industry is part of the Medical sector. This industry, currently bearing a Zacks Industry Rank of 239, finds itself in the bottom 4% echelons of all 250+ industries.
The Zacks Industry Rank gauges the strength of our industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Make sure to utilize Zacks.com to follow all of these stock-moving metrics, and more, in the coming trading sessions.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
UnitedHealth Group (UNH) Sees a More Significant Dip Than Broader Market: Some Facts to Know
UnitedHealth Group (UNH - Free Report) closed the most recent trading day at $282.65, moving -1.88% from the previous trading session. The stock's performance was behind the S&P 500's daily loss of 0.01%. Meanwhile, the Dow experienced a drop of 0.32%, and the technology-dominated Nasdaq saw an increase of 0.05%.
Shares of the largest U.S. health insurer witnessed a loss of 6.23% over the previous month, trailing the performance of the Medical sector with its loss of 1.59%, and the S&P 500's gain of 5.37%.
Market participants will be closely following the financial results of UnitedHealth Group in its upcoming release. The company plans to announce its earnings on July 29, 2025. The company is predicted to post an EPS of $4.94, indicating a 27.35% decline compared to the equivalent quarter last year. Our most recent consensus estimate is calling for quarterly revenue of $111.6 billion, up 12.89% from the year-ago period.
UNH's full-year Zacks Consensus Estimates are calling for earnings of $21.38 per share and revenue of $448.65 billion. These results would represent year-over-year changes of -22.7% and +12.08%, respectively.
Investors might also notice recent changes to analyst estimates for UnitedHealth Group. Recent revisions tend to reflect the latest near-term business trends. Hence, positive alterations in estimates signify analyst optimism regarding the business and profitability.
Our research demonstrates that these adjustments in estimates directly associate with imminent stock price performance. To exploit this, we've formed the Zacks Rank, a quantitative model that includes these estimate changes and presents a viable rating system.
The Zacks Rank system, which ranges from #1 (Strong Buy) to #5 (Strong Sell), has an impressive outside-audited track record of outperformance, with #1 stocks generating an average annual return of +25% since 1988. Over the last 30 days, the Zacks Consensus EPS estimate has witnessed a 4.02% decrease. UnitedHealth Group is currently a Zacks Rank #4 (Sell).
Digging into valuation, UnitedHealth Group currently has a Forward P/E ratio of 13.47. This valuation marks a premium compared to its industry average Forward P/E of 12.97.
We can also see that UNH currently has a PEG ratio of 1.41. This metric is used similarly to the famous P/E ratio, but the PEG ratio also takes into account the stock's expected earnings growth rate. The Medical - HMOs industry had an average PEG ratio of 0.9 as trading concluded yesterday.
The Medical - HMOs industry is part of the Medical sector. This industry, currently bearing a Zacks Industry Rank of 239, finds itself in the bottom 4% echelons of all 250+ industries.
The Zacks Industry Rank gauges the strength of our industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Make sure to utilize Zacks.com to follow all of these stock-moving metrics, and more, in the coming trading sessions.